11006PRO2020-0369OpenA Phase 2B study of selinexor (KPT-330), in combination with carfilzomib, daratumumab or pomalidomide in patients with multiple myeloma relapsing on current therapyPro2019-0125NCT04661137InstitutionalAdultTreatmentIINationalMultiple MyelomaDoucette, KimberleyGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterLymphoma; Multiple MyelomaOncology GroupLombardi Comprehensive Cancer Center (LCCC)2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>